The PARP-3 protein is closely related to the PARP-1 and PARP-2 proteins, which are involved in DNA repair and genome maintenance. Here, we characterized the biochemical properties of human PARP-3. PARP-3 is able to ADP-ribosylate itself as well as histone H1, a previously unknown substrate for PARP-3. PARP-3 is not activated upon binding to DNA and is a mono-ADP-ribosylase, in contrast to PARP-1 and PARP-2. PARP-3 interacts with PARP-1 and activates PARP-1 in the absence of DNA, resulting in synthesis of polymers of ADPribose. The N-terminal WGR domain of PARP-3 is involved in this activation. The functional interaction between PARP-3 and PARP-1 suggests that it may have a role in DNA repair. However, here we report that PARP-3 small interfering RNA-depleted cells are not sensitive to the topoisomerase I poison camptothecin, inducing DNA single-strand breaks, and repair these lesions as efficiently as wild-type cells. Altogether, these results suggest that the interaction between PARP-1 and PARP-3 is unrelated to DNA single-strand break repair.Poly(ADP-ribosylation) is a ubiquitous protein modification that is important in the regulation of transcription, cell proliferation, differentiation, and apoptosis. Poly(ADP-ribosylation) occurs in almost all nucleated cells of mammals, plants, and lower eukaryotes but is absent in yeast. It represents an immediate cellular response to DNA damage induced by ionizing radiation, alkylating agents, and oxidants (1, 2). PARP-1 (poly(ADP-ribose) polymerase 1) is an abundant nuclear protein that is activated by DNA strand breaks to modify acceptor proteins with poly(ADP-ribose) (PAR) 4 (3). PARP-1 protects DNA breaks and chromatin structure and recruits DNA repair and checkpoint proteins to sites of damage (4 -6). ADP-ribose is produced from NAD ϩ by cleavage of the glycosidic bond between nicotinamide and ribose, a reaction catalyzed by PARPs. Hydrolysis of the high energy bond between the nicotinamide and ribose produces a free energy of Ϫ34.3 kJ/mol (Ϫ8.2 kcal/mol). This energy is used by PARPs for post-translational modification of proteins by synthesizing ADP-ribose polymers attached to the proteins. PARPs can auto-modify themselves or heteromodify other proteins (1, 2).Human PARPs constitute a large family of 17 proteins encoded by different genes and displaying a conserved catalytic domain. In addition to a catalytic domain, PARP family members typically contain one or more additional motifs or domains, including zinc fingers, BRCT (BRCA1 C terminuslike) motifs, ankyrin repeats, macrodomains and different types of protein/protein interaction sites (7,8). PARP-1 has a highly conserved structure, including an N-terminal DNA-binding domain, a central auto-modification domain, and a C-terminal catalytic domain.Of the human PARP enzymes, at least PARP-1, PARP-2, and tankyrase-1 are required for the maintenance of genome stability. Inhibition of PARP-1 is synthetic lethal with defects in homologous recombination and is currently tested as a monotherapy for heritable breast and...